$HCA · HCA Healthcare, Inc.
HCA Healthcare reported Q3 2026 revenue of $19.849 billion (+3.6% YoY), GAAP diluted EPS of $7.27, and adjusted EPS of $7.22. Net income attributable to HCA declined 3.9% to $1.579 billion. The quarter included an estimated $400 million pre-tax headwind from an uninsured payer mix shift tied to health insurance exchange coverage losses. Management narrowed full-year 2026 guidance to the upper half of prior ranges and declared a $0.78/share quarterly dividend.
- Revenue rose 3.6% YoY to $19.849 billion, with same-facility admissions up 2.7% and equivalent admissions up 3.0%.
- GAAP diluted EPS of $7.27 beat adjusted EPS of $7.22; net income attributable to HCA fell 3.9% to $1.579 billion.
- Payer mix shift from uninsured volume — tied to health insurance exchange coverage losses — hit pre-tax income by approximately $400 million in Q3.
- Company repurchased 7.23 million shares for $2.97 billion in Q3; $4.24 billion remains on buyback authorization.
- Full-year 2026 guidance narrowed to the upper half of prior ranges: revenues $77B–$79.5B, adjusted EBITDA $15.4B–$16.1B, EPS $28.70–$30.50.
Extended-hours trading shows HCA at $476.00, up 2.31% from the regular-session close of $465.26, suggesting the market is rewarding the guidance raise and volume growth despite the $400M payer-mix headwind.
HCA's $400M payer-mix hit quantifies the real-world earnings impact of federal health policy changes, even as strong volumes and aggressive buybacks ($2.97B in Q3) support the stock.
HCA's results highlight a bifurcated hospital sector: strong core demand (admissions +2.7%, ER visits +5.1%) offset by a deteriorating payer mix as exchange coverage shrinks. This dynamic likely affects peers THC, UHS, and CYH similarly, though HCA's scale and buyback capacity provide a buffer.
The $400 million unfavorable payer mix shift from rising uninsured volume — driven by patients losing health insurance exchange coverage after enhanced premium tax credits expired — is a structural headwind that could persist. Federal policy changes, including the 2025 Federal Budget Act and tariff impacts on supply costs, add further uncertainty to the operating environment.